Premium
Quality assurance for care of melanoma patients based on guideline‐derived quality indicators and certification
Author(s) -
Follmann Markus,
Schadendorf Dirk,
Kochs Corinna,
Buchberger Barbara,
Winter Anna,
Wesselmann Simone
Publication year - 2014
Publication title -
jddg: journal der deutschen dermatologischen gesellschaft
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.463
H-Index - 60
eISSN - 1610-0387
pISSN - 1610-0379
DOI - 10.1111/ddg.12238
Subject(s) - guideline , certification , quality assurance , german , multidisciplinary approach , medicine , quality (philosophy) , medical physics , quality management , family medicine , operations management , external quality assessment , pathology , engineering , political science , law , management system , philosophy , archaeology , epistemology , history
Summary Background and objectives In 2013 the first German S‐3 guidelines on the diagnosis, treatment, and follow‐up of melanoma were published in the framework of the German Guideline Program on Oncology. Quality indicators were developed at the same time as the guideline development process in order to implement the guideline recommendations. Patients and methods A multidisciplinary, interprofessional working group developed quality indicators following a standardized process. Results Twelve quality indicators directly linked to guideline recommendations were generated and agreed on by consensus. They were integrated into the catalogue of requirements for dermato‐oncological centers certified by the German Cancer Society. Conclusions The close cooperation between the guideline group and commission for certification allowed the guideline contents to be implemented in the form of quality indicators in everyday clinical practice. Adherence to the guidelines is required and continuously evaluated as part of certification.